Research Article
Preferential Activity of Petiveria alliacea Extract on Primary Myeloid Leukemic Blast
Figure 4
Resistance or sensitivity to treatment with extracts and idarubicin (Ida), individually or in combination, on cells of patients with acute myeloid leukemia (AML). (a) Response of AML patients with Anamu SC, Ida, and their combination. (b) Response of AML patients with P2Et, Ida, and their combination. Red color indicates more resistance and yellow color more sensitivity. (c) Response after chemotherapy induction of the AML patients and the classification with the type of response in the in vitro test. IC50 : inhibitory concentration 50; R: response after induction chemotherapy; NR : non-response after induction chemotherapy; BR : bad responder; GR : good responder.
| (a) |
| (b) |
| (c) |